Taro Yamashita, Naohiko Koshikawa, Tetsuro Shimakami, Takeshi Terashima, Masatoshi Nakagawa, Kouki Nio, Rika Horii, Noriho Iida, Kazunori Kawaguchi, Kuniaki Arai, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Azusa Kitao, Satoshi Kobayashi, Shizuko Takahara, Yasuhito Imai, Kenichi Yoshimura, Toshinori Murayama, Yasunari Nakamoto, Eisaku Yoshida, Toru Yoshimura, Motoharu Seiki, Shuichi Kaneko – 19 February 2021

Marcus Robertson, William Chung, Dorothy Liu, Rosemary Seagar, Tess O’Halloran, Anoop N. Koshy, Mark Horrigan, Omar Farouque, Paul Gow, Peter Angus – 18 February 2021 – Coronary artery disease (CAD) confers increased perioperative risk in patients undergoing liver transplantation (LT). Although routine screening for CAD is recommended, there are limited data on the effectiveness of screening strategies. We evaluated the safety and efficacy of a 3‐tiered cardiac risk‐assessment protocol that stratifies patients based on age and traditional cardiac risk factors.

Ken Liu, Keval Pandya, Claire West, Susan Virtue, Geoffrey W. McCaughan – 17 February 2021

This on-demand webinar will update the audience on the most recent data in non-invasive testing (NITs) biomarkers in NAFLD/NASH (including use for staging, monitoring disease progression and response to therapy). We will focus on three key areas: serum-based biomarkers, imaging-based biomarkers and how to use combination or sequential NITs. At the conclusion of the webinar, learners will have an update on knowledge of various biomarkers in NAFLD and a path to apply best practices in their setting.Emmanuel A. Tsochatzis Emmanuel A.

14 February 2021

14 February 2021

14 February 2021

14 February 2021

Adam Buckholz, Robert S. Brown, Gopanandan Parthasarathy, Robert E. Schwartz, Chaitanya Allamneni, Ravi S. Vora, Adebowale O. Bamidele, David M. Salerno, Hao Wei Chen, Lauren Yang, Daryl T.Y. Lau, Jessica L. Maiers, Nidhi Jalan‐Sakrikar, Nabeel A. Wahid, Russell Rosenblatt – 14 February 2021

14 February 2021